Somatostatinrezeptor-PET/CT

Boy, C.; Poeppel, T.; Kotzerke, J.; Krause, B. J.; Amthauer, H.; Baum, R. P.; Buchmann, I.; Ezziddin, S.; Führer, D.; Gabriel, M.; Kuwert, T.; Lahner, H.; Lauenstein, T.; Maecke, H. R.; Nagarajah, J.; Rösch, F.; Scheidhauer, K.; Schmidt, M.; Walter, Martin Alexander and Bockisch, A. (2018). Somatostatinrezeptor-PET/CT. Nuklearmedizin, 57(01), pp. 4-17. Thieme 10.1055/s-0038-1636560

Full text not available from this repository. (Request a copy)

The present guideline is focused on quality assurance of somatostatin receptor PET/CT (SSTR-PET/CT) in oncology patients. The document has been developed by a multidisciplinary board of specialists providing consensus of definitions, prerequisites, methodology, operating procedures, assessment, and standardized reporting. In particular, imaging procedures for the two most commonly used radioligands of human SSTR, i. e. 68Ga-DOTATOC and 68Ga-DOTATATE are presented. Overall, SSTR-PET/CT requires close interdisciplinary communication and cooperation of referring and executing medical disciplines, taking into account existing guidelines and recommendations of the European and German medical societies, including the European Association of Nuclear Medicine (EANM), German Society for Endocrinology (DGE), German Society for Nuclear Medicine (DGN) and German Society for Radiology (DRG).

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Walter, Martin Alexander

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0029-5566

Publisher:

Thieme

Language:

German

Submitter:

Sabine Lanz

Date Deposited:

27 Jun 2019 09:57

Last Modified:

27 Jun 2019 09:57

Publisher DOI:

10.1055/s-0038-1636560

URI:

https://boris.unibe.ch/id/eprint/127540

Actions (login required)

Edit item Edit item
Provide Feedback